|30.22|| +0.72 / +2.44%|
Insulet Corp. engages in the development, manufacture and marketing of an insulin infusion system for people with insulin-dependent diabetes. Through its OmniPod Insulin Management System, the company seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod Insulin Management System is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and fully-automated cannula insertion. The company's current product offering consists of diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. Insulet was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Bedford, MA.
|Patrick J. Sullivan||President, Chief Executive Officer & Director|
|Charles Alpuche||Senior VP-Global Manufacturing & Operations|
|Michael L. Levitz||Chief Financial Officer|
|Paul Lucidi||Chief Information Officer|
|Michael P. Spears||VP-Regulatory, Revenue & Clinical Affairs|